EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Beyond treatment and cure: Burden of adverse drug reactions in a case of multidrug-resistant tuberculosis

Sagarika N. Suresh, Keertivardhan D. Kulkarni, Pothireddy Manisha Reddy

BLDE University Journal of Health Sciences · 2025

DOI: 10.4103/bjhs.bjhs_134_24 ↗
AbstractBibliografische Angaben

Abstract

Abstract: Tuberculosis is caused by Mycobacterium tuberculosis . Multidrug-resistant tuberculosis is defined as resistance to isoniazid and rifampicin, with or without resistance to other antitubercular drugs. Multiple drugs taken for a long duration in the treatment of tuberculosis, especially in multidrug-resistant tuberculosis, may produce adverse drug reactions (ADRs). We report a case of a 29-year-old female who was diagnosed with multidrug-resistant tuberculosis with resistance to rifampicin, isoniazid (high level), fluoroquinolones, and second-line injectables and started on a modified longer regimen. The patient later presented with weakness, paresthesia, numbness of bilateral upper and lower limbs, blurring of vision in both eyes, and anemia which led to challenges in management. However, discontinuation of the drugs causing adverse reactions resulted in improvement of the patient’s condition. Early recognition by active surveillance and appropriate management of ADRs are important to improve adherence to treatment and outcomes.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →